New version of CIEL concept dictionary added to dropbox

Implementing Terminology
159

New version of CIEL dictionary has been added to dropbox AND will be soon available on Open Concept Lab for April 1, 2023! This is not a trick, or Fool’s Gold :slight_smile: Lots of new content added!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes a significant number of Spanish concept names where SAME-AS SNOMED content was previously available, new concepts for PIH, MSF, Cambodia and lots of new medication concepts for the new Kenya HDD/KenyaEMR among others.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

The list of new concepts (English names):

concept_id name Class Datatype description
168058 Pabal Drug N/A
168058 Ecbosure Drug N/A
168058 Lonactene Drug N/A
168058 Riligol Drug N/A
168058 Carbetocin Drug N/A
168058 Caritec Drug N/A
168058 Cinomac Drug N/A
168058 Duratocin Drug N/A
168057 Diabetic foot ulcer risk level Question Coded
168056 Diabetic foot risk factor Question Coded
168055 History of foot amputation Finding N/A
168054 History of foot ulcer Finding N/A
168053 Foot pulse absent Diagnosis N/A
168052 Monofilament foot sensitivity test Procedure Coded
168051 Edurant Drug N/A
168051 Rilpivirine Drug N/A
168050 Vocabria Drug N/A
168050 Cabotegravir Drug N/A
168050 Apretude Drug N/A
168049 Dapivirine Drug N/A
168048 Vidala Drug N/A
168048 Vildader Drug N/A
168048 Vildalog Drug N/A
168048 Vinsorin Drug N/A
168048 Vilnip Drug N/A
168048 Vil-G Drug N/A
168048 Viglida Drug N/A
168048 Vildaphage Drug N/A
168048 Vildanat Drug N/A
168048 Vilshine Drug N/A
168048 Vildagliptin Drug N/A
168047 Agoviz Drug N/A
168047 Agotine Drug N/A
168047 Simelatin Drug N/A
168047 Noveltin Drug N/A
168047 Agodep Drug N/A
168047 Circaltin Drug N/A
168047 Agomelatine Drug N/A
168047 Agoprex Drug N/A
168047 Agopose Drug N/A
168047 Agosan Drug N/A
168047 Lupibliss Drug N/A
168046 Tuberculosis symptoms Question Coded
168045 OGTT, result Question Coded
168045 GTT, result Question Coded
168045 Oral glucose tolerance test, overall interpretation Question Coded
168044 Vortioxetine hydrobromide Drug N/A
168043 Vorsero Drug N/A
168043 Torvox Drug N/A
168043 Vortiray Drug N/A
168043 Vipca Drug N/A
168043 Trivoxetin Drug N/A
168043 Brintellix Drug N/A
168043 Vdep Drug N/A
168043 Vortica Drug N/A
168043 Vortioxetine Drug N/A
168043 Trintellix Drug N/A
168043 Voxitin Drug N/A
168043 Vortidif Drug N/A
168042 Gabapentin / mecobalamin Drug N/A
168042 Gabapentin / methylcobalamin Drug N/A
168041 Left ventricle depressed Finding N/A
168041 Depressed left ventricular ejection fraction Finding N/A
168040 Lulimac Drug N/A
168040 Emluz Drug N/A
168040 Lulizol Drug N/A
168040 L-Sys Drug N/A
168040 Lilituf Drug N/A
168040 Luliderm Drug N/A
168040 Lulibet Drug N/A
168040 Luzu Drug N/A
168040 Luly Drug N/A
168040 Luligee Drug N/A
168040 Lulifin Drug N/A
168040 Luliconazole Drug N/A
168039 Bimat-T Drug N/A
168039 Sightim Drug N/A
168039 Bimaton T Drug N/A
168039 Bimatoprost / timolol Drug N/A
168039 Intaprost T Drug N/A
168039 Careprost Plus Drug N/A
168039 Ganfort Drug N/A
168039 Xyprost TM Drug N/A
168039 Senzopt T Drug N/A
168039 Bimat LS TM Drug N/A
168039 Synoprost-T Drug N/A
168038 Fenceta Novo Drug N/A
168038 Aceclofenac / paracetamol Drug N/A
168038 Dolowin-Plus Drug N/A
168038 Anaflam XP Drug N/A
168038 Hifenac-P Drug N/A
168038 Aceclo Plus Drug N/A
168038 Parafast Drug N/A
168038 Jusgo Drug N/A
168038 Ark-AP Drug N/A
168038 Zerodol-P Drug N/A
168038 Acenac-P Drug N/A
168037 Completely dependent Misc N/A
168037 Unable to perform without assistance Misc N/A
168036 Independent with severe difficulties Misc N/A
168035 Independent with mild difficulties Misc N/A
168034 Independent Misc N/A
168034 Requires no assistance Misc N/A
168033 Aldigesic Drug N/A
168033 Aceclo-MR Drug N/A
168033 Dolofresh MR Drug N/A
168033 Acenext MR Drug N/A
168033 Acemiz-MR Drug N/A
168033 Dolokind-MR Drug N/A
168033 Hifenac-MR Drug N/A
168033 Movexx MR Drug N/A
168033 Dolowin-MR Drug N/A
168033 Acimol MR Drug N/A
168033 Facer-MR Drug N/A
168033 Aceclofenac / chlorzoxazone / paracetamol Drug N/A
168033 Aceclofenac / acetaminophen / chlorzoxazone Drug N/A
168032 Nadoxin Drug N/A
168032 Acuatim Drug N/A
168032 Nadifloxacin Drug N/A
168032 Nadiflox Drug N/A
168032 Nadixa Drug N/A
168032 Activon Drug N/A
168031 Follow-up evaluation Procedure N/A
168031 Re-evaluation procedure Procedure N/A
168030 SOAP note Question Text
168029 Hepatitis C genotype 6 Organism N/A
168028 Hepatitis C genotype 5 Organism N/A
168027 Hepatitis C genotype 4 Organism N/A
168026 Hepatitis C genotype 3 Organism N/A
168025 Hepatitis C genotype 2 Organism N/A
168024 Hepatitis C genotype 1 Organism N/A
168023 HCV genotype Test Coded Blood test that analyzes the strain of the hepatitis C virus and classify in one of the 6 most common categories
168023 Hepatitis C virus genotype Test Coded Blood test that analyzes the strain of the hepatitis C virus and classify in one of the 6 most common categories
168022 XBB.1.16 variant Misc N/A SARS-CoV-2 (COVID-19) virus variant
168022 XBB.1.16 Misc N/A SARS-CoV-2 (COVID-19) virus variant
168021 XBB.1.9 variant Misc N/A SARS-CoV-2 (COVID-19) virus variant
168020 Motivational interviewing Procedure N/A
168019 Schistosoma species identification in stool by concentration method Test Coded
168019 Schistosomiasis seen on light microscopy Test Coded
168019 S. mansoni identified in stool Test Coded
168018 Administration of Prevnar Procedure N/A
168018 Administration of 13-valent pneumococcal conjugate vaccine Procedure N/A
168017 HPV vaccination Procedure N/A
168017 Administration of human papilloma virus (HPV) vaccine Procedure N/A
168016 Shingrix Drug N/A
168016 Varicella zoster virus glycoprotein E vaccine, recombinant Drug N/A
168015 Varivax Drug N/A
168015 Zostavax Drug N/A
168015 Varicella virus vaccine, live Drug N/A
168014 Polio vaccine, bivalent, oral Drug N/A
168014 replace Drug N/A
168014 ipv Drug N/A
168013 Hemophilus influenza B immunization Procedure N/A
168013 Haemophilus influenzae B vaccination Procedure N/A
168013 Administration of conjugated Haemophilus influenzae type B vaccine Procedure N/A
168012 Polio vaccine, oral Drug N/A
168011 Administration of live, attenuated measles, mumps and rubella vaccine Procedure N/A
168011 MMR vaccination Procedure N/A
168010 Administration of influenza vaccine Procedure N/A
168010 Influenza vaccination Procedure N/A